Asahi Intecc (7747) Q4 2026 earnings summary

Executive summary

• Net sales for FYE June 2026 rose 21.2% year-over-year to ¥145,419 million, driven by strong demand and favorable exchange rates in both Medical and Device divisions.

• Operating profit surged 50.3% to ¥45,218 million, with gross profit margin improving from 67.7% to 70.4% due to productivity gains.

• Net income attributable to parent company shareholders rose 151.8% to ¥32,075 million, aided by extraordinary gains and reduced impairment losses.

• Comprehensive income reached ¥40,065 million, up 327.4% year-over-year.

Financial highlights

• Gross profit increased 26.1% year-over-year to ¥102,447 million, with margin improvement due to productivity enhancements.

• EPS climbed from ¥46.92 to ¥120.59, a 157.0% increase.

• Results exceeded the revised plan, with net sales 3.0% and operating profit 7.1% above targets.

• Total assets increased to ¥218,285 million, and net assets rose to ¥174,358 million.

• Cash and cash equivalents at period-end were ¥64,264 million, up 20.8% year-over-year.

Outlook and guidance

• For FYE June 2027, net sales are projected at ¥161,794 million (+11.3% YoY), with operating profit expected to reach ¥52,127 million (+15.3% YoY).

• Net income attributable to parent company shareholders is forecast at ¥37,832 million (+17.9% YoY).

• Growth is anticipated in both Medical and Device divisions, especially overseas, with gross profit margin forecast to rise to 70.9%.

• Annual dividend for FY2027 is planned at ¥49.91 per share, targeting a 35% payout ratio.